Forschungsbericht 2002/2003 - Medizinische Klinik 1 - Friedrich ...

inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in
skin fibroblasts. Exp Cell Res 278: 184-191
8. Ruehl M, Somasundaram R, Schoenfelder I, Farndale RW, Knight CG, Schmid M,
Ackermann R, Riecken EO, Zeitz M, Schuppan D (2002) The epithelial mitogen keratinocyte
growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.
J Biol Chem 277: 26872-26878
9. Schuppan D, Ciccocioppo R (2002) Coeliac disease and secondary autoimmunity. Dig Liver
Dis 34:13-15
10. Schuppan D, Hahn EG (2002) Gluten and the gut: lessons for immune regulation. Science
297: 2218-20
11. Somasundaram R, Ruehl M, Schaefer B, Schmid M, Ackermann R, Riecken EO, Zeitz M,
Schuppan D (2002) Interstitial collagens I, III and VI sequester and modulate the
multifunctional cytokine oncostatin M. J Biol Chem 277: 3242-3246
12. Stickel F, Brinkhaus B, Krahmer N, Seitz HK, Hahn EG, Schuppan D (2002) Antifibrotic
properties of botanicals in chronic liver disease. Hepatogastroenterology 49: 1102-1108
13. Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Cocarcinogenic effects of alcohol in
hepatocarcinogenesis. Gut 51: 132-139
14. Stölzel U, Schuppan D, Tillmann HL, Manns MP, Tannapfel A, Doss MO, Zimmer T,
Kostler E (2002) Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled
study. Cell Mol Biol 48:43-47
15. Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stolzel U (2002) Prevalence
of circulating autoantibodies in healthy individuals. Med Klin 97: 645-9
Publikationen 2003
1. Dieterich W, Trapp D, Esslinger B, Piper J, Hahn EG, Schuppan D (2003) Autoantibodies of
patients with celiac disease are insufficient to block tissue transglutaminase activity. Gut 52:
1562-6
2. Dieterich W, Esslinger B, Schuppan D (2003) Pathomechanisms in celiac disease. Int Arch
Allergy Immunol 132: 98-108
36